Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinical studies have shown that use of the BlueStar app leads to significant improvements in glycemic control. In one trial, average blood sugar levels dropped by an average of 1.9% over three months compared to only a decline of 0.7% with usual care. Hospital admissions fell by up to 58% among users over twelve months. The product has received ten FDA clearances for various features including insulin titration and AI-driven personalized recommendations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BlueStar Diabetes.